Argent BiopharmaRGTLF FCF Margin % is -1,520.18% as of Dec. 2025. The stock has 8 warning signs investors should review. Among 958 Drug Manufacturers companies, Argent Biopharma ranks worse than 97.39% on this metric.
The historical rank and industry rank for Argent Biopharma's FCF Margin % or its related term are showing as below:
RGTLF'
s FCF Margin % Range Over the Past 10 Years
Min: -4405.83 Med: -1023.78 Max: -313.78
Current: -1890.53
During the past 13 years, the highest FCF Margin % of Argent Biopharma was -313.78%. The lowest was -4405.83%. And the median was -1023.78%.
RGTLF's FCF Margin % is ranked worse than 97.39% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs RGTLF: -1890.53
Argent Biopharma FCF Margin % Related Terms
Argent Biopharma FCF Margin % Historical Data
* Premium members only.
The historical data trend for Argent Biopharma's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Argent Biopharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Argent Biopharma FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Argent Biopharma's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Argent Biopharma's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Argent Biopharma (RGTLF) has a FCF Margin % of -1,520.18% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Argent Biopharma and its competitors. According to the industry distribution chart, Argent Biopharma ranks #933 out of 958 companies in the Drug Manufacturers industry, placing it in the top 97.4%.
Is Argent Biopharma's FCF Margin % too high?
Argent Biopharma's current FCF Margin % is -1,520.18%. Based on the distribution chart, Argent Biopharma ranks #933 out of 958 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Argent Biopharma's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Argent Biopharma ranks #933 out of 958 companies for FCF Margin %. This places Argent Biopharma in the lower half of its industry. The industry median FCF Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Argent Biopharma and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Argent Biopharma's current FCF Margin % is -1,520.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Argent Biopharma stock overvalued right now?
Based on GuruFocus' analysis, Argent Biopharma (RGTLF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.02, compared to a current price of $0.03 — trading 25% above its estimated fair value. The current FCF Margin % is -1,520.18%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Argent Biopharma (RGTLF), the current FCF Margin % is -1,520.18% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Argent Biopharma Ltd is a clinical-stage biopharmaceutical company pioneering nano-engineered therapeutics that reset the balance between the nervous and immune systems. Its assets, CannEpil and CimetrA, target immune dysregulation in drug-resistant epilepsy and cytokine-driven inflammatory disorders, respectively. The products of the company include CannEpil for refractory epilepsy and cerebral palsy, CimetrA for acute lung injury and ARDS, and CogniCann for enhancing the quality of life in dementia and Alzheimer's patients, with additional treatments in development, and others. Its geographic areas are Malta, Slovenia and others, and Australia. The group generates the majority of its revenue from Slovenia and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RGTLF has been successfully added to your 